Apellis Pharmaceuticals (NASDAQ:APLS) Trading Up 5.1% on Analyst Upgrade
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was up 5.1% during trading on Friday after Wedbush raised their price target on the stock from $39.00 to $60.00. Wedbush currently has a neutral rating on the stock. Apellis Pharmaceuticals traded as high as $69.66 and last traded at $69.46. Approximately 966,493 shares traded hands during […]
More Stories
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO) Stock Price Crosses Above 200 Day Moving Average – Here’s Why
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO – Get Free Report) shares crossed above its 200-day moving average during trading on...
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO) Share Price Pass Above Two Hundred Day Moving Average – Should You Sell?
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO – Get Free Report) crossed above its 200-day moving average during...
Cheetah Canyon Resources (CVE:CHTA) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Shares of Cheetah Canyon Resources (CVE:CHTA – Get Free Report) crossed below its 200-day moving average during trading on Thursday...
ProShares K-1 Free Crude Oil ETF (BATS:OILK) Share Price Cross Below 200-Day Moving Average – Here’s What Happened
ProShares K-1 Free Crude Oil ETF (BATS:OILK – Get Free Report) shares passed below its 200-day moving average during trading...
Euclid Capital Growth ETF (BATS:EUCG) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Shares of Euclid Capital Growth ETF (BATS:EUCG – Get Free Report) passed above its 200-day moving average during trading on...
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Leelyn Smith LLC
Leelyn Smith LLC raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.6% during...